ワクチンの世界市場:弱毒生ワクチン、トキソイドワクチン、結合型ワクチン、不活化&サブユニットワクチン、組換え型ワクチン...市場調査レポートについてご紹介

【英文タイトル】Vaccines Market by Technology (Live Attenuated, Toxoid, Conjugate, Inactivated & Subunit, Recombinant), Disease Indication (Pneumococcal, Influenza, HPV, Hepatitis, Rotavirus, DTP, Polio, MMR), End User (Pediatrics, Adults) & Type - Forecasts to 2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Market Segmentation
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitation
1.5 Market Stakeholders

2 Research Methodology (Page No. – 19)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.4 Key Data From Secondary Sources
2.5 Key Data From Primary Sources
2.6 Key Industry Insights
2.7 Assumptions for the Study

3 Executive Summary (Page No. – 27)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 31)
4.1 Global Vaccines Market
4.2 Vaccines Market, By Type
4.3 Geographic Analysis: Market, By End User
4.4 Geographic Analysis: Market, By Technology
4.5 Geographical Snapshot of the Market
4.6 Lifecycle Analysis, By Region, 2016

5 Market Overview (Page No. – 36)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 High Prevalence of Diseases
5.3.1.2 Rising Government and Non-Government Funding for Vaccine Development
5.3.1.3 Increasing Investments By Companies
5.3.1.4 Increasing Government Focus on Immunization Programs
5.3.2 Restraints
5.3.2.1 Huge Capital Investments
5.3.2.2 Stringent Regulations
5.3.3 Opportunities
5.3.3.1 High Growth Prospects in Emerging Markets
5.3.3.2 Therapeutic Vaccines
5.3.3.3 Adjuvant Vaccines
5.3.4 Challenges
5.3.4.1 Inadequate Access to Vaccines
5.3.4.2 Vaccine Pricing
5.3.5 Burning Issues
5.3.5.1 Vaccine Failure
5.4 Investment Analysis
5.5 Regulatory Landscape
5.5.1 North America
5.5.2 Europe
5.5.3 Asia
5.5.4 RoW
5.6 Patent Analysis
5.7 Key Pipeline Products

6 Vaccines Market, By Technology (Page No. – 57)
6.1 Introduction
6.2 Conjugate Vaccines
6.3 Inactivated and Subunit Vaccines
6.4 Live Attenuated Vaccines
6.5 Toxoid Vaccines
6.6 Recombinant Vaccines

7 Vaccines Market, By Type (Page No. – 66)
7.1 Introduction
7.2 Monovalent Vaccines
7.3 Multivalent Vaccines

8 Vaccines Market, By Disease Indication (Page No. – 71)
8.1 Introduction
8.2 Pneumococcal Disease
8.3 DTP
8.4 Influenza
8.5 Human Papilloma Virus
8.6 Meningococcal Disease
8.7 Polio
8.8 Rotavirus
8.9 Hepatitis
8.10 MMR
8.11 Varicella
8.12 Others

9 Vaccines Market, By End User (Page No. – 87)
9.1 Introduction
9.2 Pediatrics
9.3 Adults

10 Vaccines Market, By Region (Page No. – 92)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe (RoE)
10.4 Asia
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia (RoA)
10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. – 120)
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation and Trends
11.3.1 Agreements, Collaborations, and Partnerships
11.3.2 Regulatory Approvals
11.3.3 Acquisitions
11.3.4 Expansions
11.3.5 Other Developments

12 Company Profiles (Page No. – 127)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 Introduction
12.2 Pfizer, Inc.
12.3 Glaxosmithkline, PLC.
12.4 Merck & Co., Inc.
12.5 Sanofi Pasteur
12.6 CSL Limited
12.7 Emergent Biosolutions, Inc.
12.8 Johnson & Johnson
12.9 Medimmune, LLC. (A Subsidiary of Astrazeneca)
12.10 Astellas Pharma Inc.
12.11 Serum Institute of India

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 151)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports

List of Tables (89 Tables)

Table 1 Incidence of Diseases, 2014-2015
Table 2 Nih Funding for Vaccine Research, 2012-2016 (USD Million)
Table 3 High Prevalence of Diseases to Boost the Vaccines Market
Table 4 Huge Capital Investments to Limit the Market Growth of Vaccines
Table 5 High Growth Potential in Emerging Countries to Boost the Market for Vaccines
Table 6 Immunization Coverage, By Disease, 2014
Table 7 Inadequate Access to Vaccines A Major Challenge in the Market
Table 8 Regulatory Authorities in Europe
Table 9 Regulatory Authorities in Asia
Table 10 Key Pipeline Vaccines
Table 11 Market Size, By Technology, 2014–2021 (USD Million)
Table 12 Conjugate Vaccines Market Size, By Region, 2014–2021 (USD Million)
Table 13 Examples of Inactivated and Subunit Vaccines
Table 14 Inactivated and Subunit Vaccines Market Size, By Region, 2014–2021 (USD Million)
Table 15 Live Attenuated Vaccines Market Size, By Region, 2014–2021 (USD Million)
Table 16 Toxoid Vaccines Market Size, By Region, 2014–2021 (USD Million)
Table 17 Recombinant Vaccines Market Size, By Region, 2014–2021 (USD Million)
Table 18 Vaccines Market Size, By Type, 2014–2021 (USD Million)
Table 19 Monovalent Vaccines Market Size, By Region, 2014–2021 (USD Million)
Table 20 Examples of Multivalent Vaccines
Table 21 Multivalent Vaccines Market Size, By Region, 2014–2021 (USD Million)
Table 22 Market Size, By Disease Indication, 2014–2021 (USD Million)
Table 23 List of Pneumococcal Vaccines
Table 24 Market Size for Pneumococcal Disease, By Region, 2014–2021 (USD Million)
Table 25 List of DTP Vaccines
Table 26 Market Size for DTP, By Region, 2014–2021 (USD Million)
Table 27 List of Influenza Vaccines
Table 28 Market Size for Influenza, By Region, 2014–2021 (USD Million)
Table 29 List of Hpv Vaccines
Table 30 Market for Hpv, By Region, 2014–2021 (USD Million)
Table 31 List of Meningococcal Vaccines
Table 32 Market Size for Meningococcal Disease, By Region, 2014–2021 (USD Million)
Table 33 List of Polio Vaccines
Table 34 Polio Market Size, By Region, 2014–2021 (USD Million)
Table 35 List of Rotavirus Vaccines
Table 36 Market Size for Rotavirus, By Region, 2014–2021 (USD Million)
Table 37 List of Hepatitis Vaccines
Table 38 Market Size for Hepatitis, By Region, 2014–2021 (USD Million)
Table 39 List of MMR Vaccines
Table 40 Market Size for MMR, By Region, 2014–2021 (USD Million)
Table 41 List of Varicella Vaccines
Table 42 Market Size for Varicella, By Region, 2014–2021 (USD Million)
Table 43 List of Other Vaccines
Table 44 Market Size for Other Diseases, By Region, 2014–2021 (USD Million)
Table 45 Market Size, By End User, 2014–2021 (USD Million)
Table 46 Market Size for Pediatrics, By Region, 2014–2021 (USD Million)
Table 47 North America: Market Size for Pediatrics, By Country, 2014–2021 (USD Million)
Table 48 Market Size for Adults, By Region, 2014–2021 (USD Million)
Table 49 North America: Market Size for Adults, By Country, 2014–2021 (USD Million)
Table 50 Market Size, By Region, 2014–2021 (USD Million)
Table 51 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 52 North America: Market Size, By Technology, 2014–2021 (USD Million)
Table 53 North America: Vaccines Market Size, By Type, 2014–2021 (USD Million)
Table 54 North America: Vaccines Market Size, By Disease Indication, 2014–2021 (USD Million)
Table 55 North America: Vaccines Market Size, By End User, 2014–2021 (USD Million)
Table 56 U.S.: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 57 U.S.: Vaccines Market Size, By End User, 2014–2021 (USD Million)
Table 58 Canada: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 59 Canada: Vaccines Market Size, By End User, 2014–2021 (USD Million)
Table 60 Europe: Vaccines Market Size, By Country, 2014–2021 (USD Million)
Table 61 Europe: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 62 Europe: Vaccines Market Size, By Type, 2014–2021 (USD Million)
Table 63 Europe: Vaccines Market Size, By Disease Indication, 2014–2021 (USD Million)
Table 64 Europe: Vaccines Market Size, By End User, 2014–2021 (USD Million)
Table 65 Germany: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 66 U.K.: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 67 France: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 68 Italy: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 69 Spain: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 70 RoE: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 71 Asia: Health Expenditure Per Capita, By Country, 2000 & 2014 (USD)
Table 72 Asia: Vaccines Market Size, By Country, 2014–2021 (USD Million)
Table 73 Asia: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 74 Asia: Vaccines Market Size, By Type, 2014–2021 (USD Million)
Table 75 Asia: Vaccines Market Size, By Disease Indication, 2014–2021 (USD Million)
Table 76 Asia: Vaccines Market Size, By End User, 2014–2021 (USD Million)
Table 77 Japan: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 78 China: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 79 India: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 80 RoA: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 81 RoW: Vaccines Market Size, By Technology, 2014–2021 (USD Million)
Table 82 RoW: Vaccines Market Size, By Type, 2014–2021 (USD Million)
Table 83 RoW: Vaccines Market Size, By Disease Indication, 2014–2021 (USD Million)
Table 84 RoW: Vaccines Market Size, By End User, 2014–2021 (USD Million)
Table 85 Agreements, Collaborations, and Partnerships, 2013-2016
Table 86 Regulatory Approvals, 2013-2016
Table 87 Acquisitions, 2013-2016
Table 88 Expansions, 2013-2016
Table 89 Other Developments, 2013-2016


List of Figures (55 Figures)

Figure 1 Vaccines Market Segmentation
Figure 2 Research Design
Figure 3 Top-Down Approach
Figure 4 Bottom-Up Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Vaccines Market Size, By Technology, 2016 vs 2021 (USD Million)
Figure 8 Global Vaccines Market Size, By Type, 2016 vs 2021 (USD Million)
Figure 9 Global Vaccines Market, By Disease Indication, 2016
Figure 10 Global Vaccines Market Size, By End User, 2016 vs 2021 (USD Million)
Figure 11 Global Vaccines Market, By Region, 2016 (USD Million)
Figure 12 High Prevalence of Diseases and Rising Government & Non-Government Funding for Vaccine Development Primary Growth Drivers for the Global Vaccines Market
Figure 13 Monovalent Vaccines Segment to Witness High Growth During the Forecast Period
Figure 14 Pediatrics Segment to Dominate the Vaccines Market in 2021
Figure 15 Conjugate Vaccines Segment to Account for the Largest Market Share in 2016
Figure 16 U.S. to Dominate the Vaccines Market in 2016
Figure 17 Asia to Witness the Highest Growth Rate in the Vaccines Market During the Forecast Period
Figure 18 Vaccine Market Segmentation
Figure 19 Vaccine Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 Investors Play an Important Role in the Vaccines Market
Figure 21 Vaccine Funding, By Investor, 2014
Figure 22 Gavi Vaccine Funding, By Type of Investor, 2014
Figure 23 HIV Preventive Vaccines R&D Funding, By Investor, 2014
Figure 24 Regulatory Approval Process for Vaccines
Figure 25 North America Accounted for the Largest Number of Patent Filings in 2012
Figure 26 The U.S. Accounted for Largest Number of Patent Filings Across the Globe (2012)
Figure 27 Conjugate Vaccines Segment to Dominate the Vaccines Market During the Forecast Period
Figure 28 Asian Market for Live Attenuated Vaccines to Register the Highest CAGR During the Forecast Period
Figure 29 North America is Expected to Dominate the Recombinant Vaccines Market During the Forecast Period
Figure 30 Monovalent Vaccines to Dominate the Global Vaccines Market From 2016 to 2021
Figure 31 North America is Expected to Dominate the Multivalent Vaccines Market During the Forecast Period
Figure 32 Pneumococcal Disease Segment Expected to Dominate the Market During the Forecast Period
Figure 33 Asia is Expected to Grow at the Highest CAGR in the Influenza Disease Segment During the Forecast Period
Figure 34 North America to Dominate the Meningococcal Disease Market During the Forecast Period
Figure 35 Asian Market for Hepatitis Vaccines to Grow at the Highest CAGR During the Forecast Period
Figure 36 The Pediatrics End-User Segment Dominates the Global Vaccines Market in 2016
Figure 37 Asia to Witness the Highest Growth Rate in the Vaccines Market for Adults During the Forecast Period
Figure 38 Geographic Snapshot (2016): Emerging Markets to Offer Growth Opportunities
Figure 39 Geographic Benchmarking for Vaccines Technology Market
Figure 40 North America: Vaccines Market Snapshot, 2016
Figure 41 Europe: Vaccines Market Snapshot, 2016
Figure 42 Asia: Vaccines Market Snapshot, 2016
Figure 43 Organic and Inorganic Growth Strategies Adopted By Key Market Players From 2013 to 2016
Figure 44 Global Vaccines Market Share, By Key Player, 2015
Figure 45 Battle for Market Share: Agreements, Collaborations, and Partnerships Were the Preferred Strategies By Market Players
Figure 46 Product Benchmarking for Top 4 Market Players
Figure 47 Pfizer, Inc.: Company Snapshot
Figure 48 Glaxosmithkline, PLC.: Company Snapshot
Figure 49 Merck & Co., Inc.: Company Snapshot
Figure 50 Sanofi Pasteur: Company Snapshot
Figure 51 CSL Limited: Company Snapshot
Figure 52 Emergent Biosolutions: Company Snapshot
Figure 53 Johnson & Johnson: Company Snapshot
Figure 54 Astrazeneca : Company Snapshot
Figure 55 Astellas Pharma Inc.: Company Snapshot


【レポート販売概要】

■ タイトル:ワクチンの世界市場:弱毒生ワクチン、トキソイドワクチン、結合型ワクチン、不活化&サブユニットワクチン、組換え型ワクチン
■ 英文:Vaccines Market by Technology (Live Attenuated, Toxoid, Conjugate, Inactivated & Subunit, Recombinant), Disease Indication (Pneumococcal, Influenza, HPV, Hepatitis, Rotavirus, DTP, Polio, MMR), End User (Pediatrics, Adults) & Type - Forecasts to 2021
■ 発行日:2016年8月9日
■ 調査会社:MarketsandMarkets
■ 商品コード:BT-3113
■ 調査対象地域:グローバル
  • 防弾チョッキの世界市場2016-2020
    About Bullet Proof Vest A bulletproof vest, also known as a bullet-resistant vest or ballistic vest is a type of personal protective equipment. It is used by the military, law enforcement personals, and many times by civilians as a protective cover against bullets and shrapnel from explosions. Soft bulletproof vests weigh less and provide protection against small-caliber handguns. Hard bulletproof …
  • 3D細胞培養の世界市場予測(~2021)
    The global 3D cell culture market size is expected to reach USD 1345.2 Million by 2021, at a CAGR of 23.6% during the forecast period of 2016 to 2021. The report on global 3D cell culture market analyzes and segments the market on the basis of technology, product, application, and region. It analyzes the competitive developments, such as alliances, joint ventures, and mergers & acquisitions in the …
  • 心房細動治療薬の世界市場2015-2019
    About Atrial Fibrillation According to the NHLBI of the NIH in the US, atrial fibrillation is one of the commonest type of arrhythmia. Atrial fibrillation is similar to another type of arrhythmia of the heart, superventricular tachycardia. The chief difference between these two types of arrhythmia is the consistency of the beats. In superventricular tachycardia, the heart beats are regular and at …
  • Semaglutide (Type 2 Diabetes):市場予測と分析(~2022)
    Semaglutide (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Semaglutide (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked by a late-stage pipeline filled with me-too drugs, this market will undergo substantial growth between 2012 and 20 …
  • Wintershall Holding GmbH:石油・ガスの開発・生産動向及びコスト分析- 2012
    Wintershall Holding GmbH Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Wintershall Holding GmbH Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
  • タンパク質発現の世界市場分析:発現システム別(原核細胞、哺乳動物細胞)、製品別(試薬、コンピテントセル)、用途別(治療、工業用)、エンドユーザー別、セグメント予測、2014-2025
    The global protein expression market is expected to reach USD 3.0 billion by the year 2025 growing at a CAGR of 10.4%, according to a new report by Grand View Research, Inc. The growing demand for biologics and expansion of the biopharmaceutical industry have resulted in massive growth of the protein expression market. Rising demand for therapeutic proteins such as insulin, hormones, monoclonal an …
  • 高等教育向けクラウド式コンテンツ管理サービスの世界市場2016-2020
    About Cloud Computing Cloud computing is being increasingly adopted by educational institutions as it offers flexible and scalable services at nominal costs, such as consumption-based payment models. These exempt educational institutions from investments in outdated hardware and applications and enable them to adapt the latest technologies. In addition, apart from providing numerous client platfor …
  • 加入者データ管理の世界市場予測(~2021):ソリューション別(方針管理、加入者データ提携、ID管理、利用者データ貯蔵)、ネットワーク種類別、用途種類別、組織規模別、配置種類別、地域別
    “Factors such as increasing subscriber demand for Long-Term Evolution (LTE) & Voice over LTE (VoLTE), movement of telcos towards Network Function Virtualization (NFV), and need to reduce Operational Expenditure (OpEx) & enable cross-network consolidation are driving the Subscriber Data Management (SDM) market.”The SDM market size is estimated to grow from USD 1.97 billion in 2016 to USD 4.44 billi …
  • カボチャ種子の世界市場
    About Pumpkin SeedsPumpkin seeds are the edible kernels of pumpkins. The seeds are concentrated sources of many vitamins, minerals, antioxidants, and vital amino acids. They contain zinc, magnesium, copper, and iron in substantial quantities. They can be found in various forms: hulled, roasted, and raw. Technavio’s analysts forecast the global Pumpkin Seeds market to grow at a CAGR of 15.07% durin …
  • 手洗器の世界市場2016-2020
    Technavio’s research analysts predict the global wash basin market to grow at a CAGR of around 9% during the forecast period. The growing infrastructure development in sectors such as water, power, and transportation due to increasing urbanization across the world is the primary growth driver for this market. Demographic changes like aging population influence the type and amount of spending on in …
  • 血餅/血栓管理デバイスの世界市場2015-2019
    About clot management devices A blood clot or thrombus is the end stage of blood coagulation process in hemostasis. Blood clot is the body's response to an injury to prevent bleeding. However, a clot can be harmful when it forms abnormally to obstruct blood flow through healthy blood vessels. This condition is called thrombosis. A blood clot in arteries can lead to heart attack, while blood clot f …
  • 世界の電子料金収受(ETC)システム市場分析及び予測(2013 – 2020)
    ※当レポートは電子料金収受(ETC)システム市場の成長要因、主要イシュー、バリューチェーン、市場分析、競争環境、関連企業概要、並びにAvi、Avc、Ves商品別、技術別、応用分野別、地域別市場予測をまとめました。 Electronic Toll Collection system is mainly installed for the ease of transportation. In this system, tolls are collected with the help of electronic equipment installed on the roadside and without reducing the speed of the vehicle or stopping it. An ETC system consists of four segments named …
  • 医療レポート:Hemophilia-疫学予測(~2022)
    EpiCast Report: Hemophilia - Epidemiology Forecast to 2022 Summary Hemophilia is an X-linked hereditary bleeding disorder characterized by impaired blood coagulation as a result of deficiencies in the production or function of coagulation factor VIII (hemophilia A) or factor IX (hemophilia B). Because of the deficiency of coagulation factor, hemophilia patients have a tendency for bleeding in join …
  • 世界における次世代太陽光発電用材料市場(2014-2021)
    The PV boom and bust has rebooted efforts to commercialize the next generation of materials platforms for solar panels. There has recently been a resurgence of the solar panel industry but many of the surviving firms are Chinese companies making conventional crystalline silicon (c-Si) panels. Also surviving is First Solar with its stable and ongoing production of CdTe. With the solar panel industr …
  • ヨーロッパのキャンプ用テント市場2016-2020
    About Camping Tent Market in Europe A diverse range of camping equipment is used for camping, hiking, and climbing. The equipment available in the market varies in size, insulation, design, material, temperature rating, and other parameters. Countries like Germany, France, the UK, Italy, and Spain are witnessing a rise in the number of campers over the past few years. The rising interest in outdoo …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。